Aflac Inc. Continues to Demonstrate Resilience and Growth

Aflac Inc.’s stock price has experienced a notable uptick over the past few years, with its value surging from approximately $54 per share in 2022 to a current valuation of over $101 per share in 2025. This substantial gain underscores the company’s ability to adapt and thrive in a rapidly evolving market.

As a leading provider of supplemental insurance products, Aflac Inc. has consistently demonstrated its commitment to delivering value to investors. The company’s dedication to its core mission – providing financial support to families affected by illness or injury – remains unwavering, with a particular focus on helping children with cancer and blood disorders.

The Aflac Childhood Cancer Foundation has been at the forefront of this effort, awarding grants to Child Life programs across the US. These initiatives not only underscore the company’s philanthropic spirit but also highlight its commitment to making a positive impact on the lives of those in need.

Key Highlights:

• Aflac Inc.’s stock price has increased by approximately 87% over the past three years
• The company’s current valuation stands at over $101 per share
• The Aflac Childhood Cancer Foundation has awarded grants to numerous Child Life programs in the US
• Aflac Inc.’s commitment to its core mission remains unwavering, with a focus on helping children with cancer and blood disorders

As the company continues to navigate the complexities of the insurance industry, Aflac Inc.’s resilience and growth are a testament to its ability to adapt and thrive in a rapidly evolving market. With a strong track record of delivering value to investors and a commitment to making a positive impact on the lives of those in need, Aflac Inc. is poised to remain a leader in the industry for years to come.